Rapid and reliable detection of G6PD mutations using recombinase polymerase amplification coupled with lateral flow strip

dc.contributor.authorJacob B.A.C.
dc.contributor.authorSongsungthong W.
dc.contributor.authorLeartsakulpanich U.
dc.contributor.authorBoonyuen U.
dc.contributor.correspondenceJacob B.A.C.
dc.contributor.otherMahidol University
dc.date.accessioned2025-05-13T18:05:25Z
dc.date.available2025-05-13T18:05:25Z
dc.date.issued2025-06-15
dc.description.abstractGlucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy, affecting approximately 500 million people worldwide. It results from inherited mutations in the G6PD gene, causing increased susceptibility to drug-induced hemolytic anemia and severe neonatal jaundice. While phenotypic tests are commonly used, genetic testing is increasingly recognized for its value in the accurate diagnosis of G6PD deficiency, especially in heterozygous females and newborns. This study aimed to develop and evaluate a rapid, field-deployable genetic test for the detection of four common G6PD variants in Thailand: G6PD Gaohe (c.95A > G), G6PD Mahidol (c.487G > A), G6PD Viangchan (c.871G > A), and G6PD Canton (c.1376G > T). The assays utilize recombinase polymerase amplification with allele-specific primers incorporating locked nucleic acids to enhance specificity, followed by lateral flow strip detection for visual readout. The assays deliver results within 45 min at 37 ˚C. Singleplex detection demonstrated 100 % diagnostic sensitivity (Confidence interval (CI): 95.01–100.0 %) and specificity (CI: 95.49–100.0 %). Duplex assays (Gaohe + Canton and Mahidol + Viangchan) also demonstrated 100 % diagnostic sensitivity (CI: 94.87–100.0 %) and specificity (CI: 91.19–100.0 %). Limits of detection (LOD) for singleplex assays were 0.25, 1.00, 0.50, and 0.50 ng/µL, for Gaohe, Mahidol, Viangchan, and Canton, respectively. Duplex assays showed LODs of 0.10 ng/μL for Mahidol + Viangchan and 10.00 ng/μL for Gaohe + Canton. Band intensity differences ranged from 5.25 to 19.61 pixels between mutant, wild-type, and nontarget alleles, enabling clear allele discrimination. This innovative diagnostic tool offers a rapid, reliable, and accessible solution for point-of-care genetic testing, with the potential to improve clinical management and healthcare outcomes in regions with a high burden of G6PD deficiency.
dc.identifier.citationClinica Chimica Acta Vol.574 (2025)
dc.identifier.doi10.1016/j.cca.2025.120345
dc.identifier.eissn18733492
dc.identifier.issn00098981
dc.identifier.scopus2-s2.0-105004316441
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/110066
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.subjectMedicine
dc.titleRapid and reliable detection of G6PD mutations using recombinase polymerase amplification coupled with lateral flow strip
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105004316441&origin=inward
oaire.citation.titleClinica Chimica Acta
oaire.citation.volume574
oairecerif.author.affiliationFaculty of Tropical Medicine, Mahidol University
oairecerif.author.affiliationThailand National Center for Genetic Engineering and Biotechnology

Files

Collections